International Journal of Drug Policy
Volume 14, Issue 5 , Pages 373-379 , December 2003

Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA

  • Sherry Deren

      Affiliations

    • Institute for AIDS Research, Center for Drug Use and HIV Research, National Development & Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-212-845-4463; fax: +1-917-438-0894.
  • ,
  • Crystal Fuller

      Affiliations

    • Center for Urban Epidemiologic Studies, New York Academy of Medicine, 1216 Fifth Avenue, New York, NY 10029, USA
    • Tel.: +1-212-822-7391; fax: +1-212-876-6220.
  • ,
  • Enrique R Pouget

      Affiliations

    • Institute for AIDS Research, Center for Drug Use and HIV Research, National Development & Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    • Tel.: +1-212-845-4488; fax: +1-917-438-0894.
  • ,
  • Shannon Blaney

      Affiliations

    • Center for Urban Epidemiologic Studies, New York Academy of Medicine, 1216 Fifth Avenue, New York, NY 10029, USA
    • Tel.: +1-212-419-3541; fax: +1-212-876-6220.
  • ,
  • Stephanie Tortu

      Affiliations

    • Department of Community Health Sciences, Tulane University School of Public Health and Tropical Medicine, 1140 Canal Street, Suite 2301, New Orleans, LA 70112, USA
    • Tel.: +1-504-988-4535; fax: +1-504-584-3540.
  • ,
  • Sung-Yeon Kang

      Affiliations

    • Institute for AIDS Research, Center for Drug Use and HIV Research, National Development & Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    • Tel.: +1-212-845-4457; fax: +1-917-438-0894.
  • ,
  • James M McMahon

      Affiliations

    • Institute for AIDS Research, Center for Drug Use and HIV Research, National Development & Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    • Tel.: +1-212-845-4553; fax: +1-917-438-0894.
  • ,
  • Jonny F Andia

      Affiliations

    • Institute for AIDS Research, Center for Drug Use and HIV Research, National Development & Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    • Tel.: +1-212-845-4580; fax: +1-917-438-0894.
  • ,
  • Don C Des Jarlais

      Affiliations

    • Institute for AIDS Research, Center for Drug Use and HIV Research, National Development & Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    • The Edmond de Rothschild Foundation, Chemical Dependency Institute, Beth Israel Medical Center, 1st Avenue and 16th Street, New York, NY 10003, USA
    • Tel.: +1-212-387-3803/845-4463; fax: +1-212-387-3897/917-438-0894.
  • ,
  • Bruce Johnson

      Affiliations

    • Institute for Special Populations Research, National Development & Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    • Tel.: +1-212-845-4500; fax: +1-917-438-0894.
  • ,
  • Andrew Rosenblum

      Affiliations

    • Institute for Treatment and Services Research, National Development & Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    • Tel.: +1-212-845-4528; fax: +1-917-438-0894.
  • ,
  • David Vlahov

      Affiliations

    • Center for Urban Epidemiologic Studies, New York Academy of Medicine, 1216 Fifth Avenue, New York, NY 10029, USA
    • Tel.: +1-212-822-7391; fax: +1-212-876-6220.

Received 1 December 2002 ,Revised 15 March 2003 ,Accepted 18 June 2003.

References 

  1. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics. 1955;11:375–386
  2. Case P, Beckett GA, Jones TS. Access to sterile syringes in Maine: Pharmacy practice after the 1993 repeal of the syringe prescription law. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18(Suppl. 1):S94–S101
  3. Cochran WG. Some methods for strengthening the common χ2 tests. Biometrics. 1954;10:417–451
  4. Cotton-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. Journal of Acquired Immune Deficiency Syndromes. 2001;27(2):183–192
  5. Deren S, Oliver-Velez D, Finlinson A, Robles R, Andia J, Colon HM, et al.  Integrating qualitative and quantitative methods: Comparing HIV-related risk behaviours among Puerto Rican drug users in Puerto Rico and New York. Substance Use and Misuse. 2003;38(2):1–24
  6. Des Jarlais DC, Marmor M, Friedmann P, Titus S, Aviles E, Deren S, et al.  HIV incidence among injection drug users in New York City, 1992–1997: Evidence for a declining epidemic. American Journal of Public Health. 2000;90(3):352–359
  7. Des Jarlais DC, McKnight C, Friedmann P. Legal syringe purchases by injection drug users in Brooklyn and Queens, 2000–2001. Journal of the American Pharmaceutical Association. 2002;42:S73–S76
  8. Finkelstein R, Tiger R, Greenwald R, Mukherjee R. Pharmacy syringe sales practices during the first year of expanded syringe availability in New York City 2000–2001. Journal of the American Pharmaceutical Association. 2002;42:S83–S87
  9. Fuller CM, Ahern J, Vadnai L, Coffin PO, Galea S, Factor SH, et al.  Impact of increased syringe access: Preliminary findings of injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. Journal of the American Pharmaceutical Association. 2002;42:S77–S82
  10. Gostin LO, Lazzarini Z, Jones TS, Flaherty K. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles. Journal of the American Medical Association. 1997;277(1):53–62
  11. Groseclose SL, Weinstein B, Jones TS, Valleroy LA, Fehrs LJ, Kassler WJ. Impact of increased legal access to needles and syringes on practices of injecting drug users and police officers—Connecticut, 1992–1993. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1995;10(1):82–89
  12. Klein SJ, Harris-Valente K, Candelas AR, Radigan M, Narcisse-Pean M, Tesoriero JM, et al.  What do pharmacists think about New York State’s new non-prescription syringe sale program? Results of a survey. Journal of Urban Health. 2001;78(4):679–689
  13. Lurie, P. (1993). The public-health impact of needle-exchange programs in the United States and abroad: Summary, conclusions, and recommendations. San Francisco, CA: Institute for Health Policy Studies, University of California.
  14. Maslow CB, Friedman SR, Perlis TE, Rockwell R, Des Jarlais DC. Changes in HIV seroprevalence and related behaviours among male injection drug users who do and do not have sex with men: New York City, 1990–1999. American Journal of Public Health. 2002;92(3):382–384
  15. New York State Department of Health. (2001). Part 80—Rules and regulations on controlled substances [Statutory authority: Public health law article 33, Section 3381 (6)(e)]. Retrieved November 8, 2002 from http://www.health.state.ny.us/nysdoh/hivaids/esap/fullregs.htm.
  16. New York State Department of Health, AIDS Institute. (2002). ESAP implementation provider registration update, September 2002. Albany, NY: AIDS Institute.
  17. Obadia Y, Feroni I, Perrin V, Vlahov D, Moatti JP. Syringe vending machine for injection drug users: An experiment in Marseille, France. American Journal of Public Health. 1999;89(12):1852–1854
  18. Penal Law of the State of New York. (2001). Criminally possessing a hypodermic needle 220.45. Binghamton, NY: Gould Publications.
  19. Singer M, Baer HA, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: Follow-up findings from Hartford, Connecticut. Public Health Reports. 1998;113(Suppl. 1):81–89
  20. Tortu, S., McMahon, J., Hamid, R., & Pouget, E. R. (2002). Relationship dynamics and disease risk among drug-using women and their primary male sex partners in New York City. In Proceedings of the XIV International Conference on AIDS, Barcelona, Spain.
  21. Valleroy LA, Weinstein B, Jones TS, Groseclose SL, Rolfs RT, Kassler WJ. Impact of increased legal access to needles and syringes on community pharmacies’ needle and syringe sales—Connecticut, 1992–1993. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1995;10(1):73–81
  22. Weiser, B. (2002, 21 November). Judge backs drug users in needle-exchange plans. The New York Times, B4.
  23. Wright-De Aguero L, Weinstein B, Jones TS, Miles J. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers’ practice. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18(Suppl. 1):S102–S110

PII: S0955-3959(03)00137-3

doi: 10.1016/S0955-3959(03)00137-3

International Journal of Drug Policy
Volume 14, Issue 5 , Pages 373-379 , December 2003